CPH Group AG

SWX-CPHN
SIX Swiss Exchange
Materials Paper & Paper Products
Global Rank
#13777
Country Rank
#154
Market Cap
545.97 M
Price
91.09
Change (%)
0.27%
Volume
207

CPH Group AG's latest marketcap:

545.97 M

As of 08/10/2025, CPH Group AG's market capitalization has reached $545.97 M. According to our data, CPH Group AG is the 13777th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 545.97 M
Revenue (ttm) 398.94 M
Net Income (ttm) 37.66 M
Shares Out 5.99 M
EPS (ttm) 6.28
Forward PE 11.89
Ex-Dividend Date 03/20/2025
Earnings Date 07/18/2025
Market Cap Chart
Data Updated: 08/10/2025

CPH Group AG's yearly market capitalization.

CPH Group AG has seen its market value grow from ₣338.7 M to ₣441.14 M since 2014, representing a total increase of 30.25% and an annual compound growth rate (CAGR) of 2.52%.
Date Market Cap(₣) Market Cap(USD) Change (%) Global Rank
08/10/2025 ₣441.14 M $545.97 M 0.25% 13777
12/30/2024 ₣440.05 M $484.53 M -13.72% 13205
12/29/2023 ₣510 M $605.75 M 8.97% 11717
12/30/2022 ₣468 M $505.95 M 27.88% 12173
12/30/2021 ₣365.98 M $401.15 M -15.98% 14731
12/30/2020 ₣435.56 M $491.96 M -8.33% 11676
12/30/2019 ₣475.12 M $490.37 M -3.99% 10149
12/28/2018 ₣494.85 M $503.81 M 54.07% 9073
12/29/2017 ₣321.2 M $329.19 M 33.89% 12469
12/30/2016 ₣239.89 M $235.12 M 27.37% 12154

Company Profile

About CPH Group AG

CPH Group AG, along with its subsidiaries, specializes in the development, manufacturing, and distribution of chemical products and pharmaceutical packaging solutions. The company operates across Europe, Asia, and the Americas, serving a diverse clientele in the pharmaceutical sector.

Core Divisions

  • Chemistry Division:

    This division focuses on molecular sieves, special zeolites, chromatography gels, and deuterated solvents, marketed under the Zeochem brand.

  • Packaging Division:

    Provides high-quality PVC mono films and coated PVdC barrier films tailored for pharmaceutical applications, sold under the Perlen Packaging brand.

Additional Operations

Beyond its core divisions, CPH Group AG also produces newsprint and magazine paper, catering to the printing and publishing industries.

Company Background

Founded in 1818, CPH Group AG is headquartered in Root, Switzerland, with a long-standing reputation for innovation and quality in its respective markets.

Frequently Asked Questions

  • What is CPH Group AG's (SWX-CPHN) current market cap?
    As of 08/10/2025, CPH Group AG (including the parent company, if applicable) has an estimated market capitalization of $545.97 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • CPH Group AG global market capitalization ranking is approximately 13777 as of 08/10/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.